LEXAGENE PROVIDES PRODUCT DEVELOPMENT UPDATE

The development of Lexagene Holdings Inc.'s alpha prototype remains on track and is scheduled to be completed by the end of November, 2017. The company is following a phase-gate approach for product development. In phase I, which was completed in [...]